

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.62230353 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62230353 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 4.53929609 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 4.30909516 |
| 5 | tryptophan catabolic process (GO:0006569) | 4.30909516 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 4.30909516 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.25026567 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.25026567 |
| 9 | tryptophan metabolic process (GO:0006568) | 4.21266877 |
| 10 | proteasome assembly (GO:0043248) | 4.11720734 |
| 11 | mitochondrial RNA metabolic process (GO:0000959) | 4.02639842 |
| 12 | pseudouridine synthesis (GO:0001522) | 3.99028083 |
| 13 | respiratory chain complex IV assembly (GO:0008535) | 3.83801832 |
| 14 | maturation of 5.8S rRNA (GO:0000460) | 3.83303556 |
| 15 | transcription from mitochondrial promoter (GO:0006390) | 3.81042161 |
| 16 | cullin deneddylation (GO:0010388) | 3.79238820 |
| 17 | DNA replication checkpoint (GO:0000076) | 3.74908357 |
| 18 | protein deneddylation (GO:0000338) | 3.71073141 |
| 19 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.68305259 |
| 20 | cellular biogenic amine catabolic process (GO:0042402) | 3.67998467 |
| 21 | amine catabolic process (GO:0009310) | 3.67998467 |
| 22 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.66051071 |
| 23 | termination of RNA polymerase III transcription (GO:0006386) | 3.66051071 |
| 24 | nucleobase biosynthetic process (GO:0046112) | 3.62364452 |
| 25 | regulation of mitochondrial translation (GO:0070129) | 3.62164409 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.59340744 |
| 27 | protein carboxylation (GO:0018214) | 3.59340744 |
| 28 | DNA strand elongation (GO:0022616) | 3.57559850 |
| 29 | aldehyde catabolic process (GO:0046185) | 3.56575886 |
| 30 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.53323979 |
| 31 | formation of translation preinitiation complex (GO:0001731) | 3.50418293 |
| 32 | valine metabolic process (GO:0006573) | 3.46977059 |
| 33 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.45568188 |
| 34 | ribosome assembly (GO:0042255) | 3.45509849 |
| 35 | purine nucleobase biosynthetic process (GO:0009113) | 3.43829673 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.42622277 |
| 37 | rRNA modification (GO:0000154) | 3.38869935 |
| 38 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.38438548 |
| 39 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.38438548 |
| 40 | spliceosomal snRNP assembly (GO:0000387) | 3.38357690 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.37960995 |
| 42 | bile acid biosynthetic process (GO:0006699) | 3.33508456 |
| 43 | peptidyl-histidine modification (GO:0018202) | 3.33132752 |
| 44 | signal peptide processing (GO:0006465) | 3.30929910 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 3.30141424 |
| 46 | NAD biosynthetic process (GO:0009435) | 3.29219250 |
| 47 | chromatin remodeling at centromere (GO:0031055) | 3.26639848 |
| 48 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.26250968 |
| 49 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26166340 |
| 50 | protein localization to kinetochore (GO:0034501) | 3.25962850 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25469236 |
| 52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.25180377 |
| 53 | nucleotide transmembrane transport (GO:1901679) | 3.24872571 |
| 54 | NADH dehydrogenase complex assembly (GO:0010257) | 3.24473588 |
| 55 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.24473588 |
| 56 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.24473588 |
| 57 | rRNA processing (GO:0006364) | 3.23127527 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.22616922 |
| 59 | negative regulation of ligase activity (GO:0051352) | 3.22616922 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.22187563 |
| 61 | CENP-A containing nucleosome assembly (GO:0034080) | 3.22078160 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 3.21848127 |
| 63 | ribosomal small subunit assembly (GO:0000028) | 3.20211507 |
| 64 | superoxide anion generation (GO:0042554) | 3.19897552 |
| 65 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.18580644 |
| 66 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.18580644 |
| 67 | protein complex biogenesis (GO:0070271) | 3.18154119 |
| 68 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.17223744 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.16781070 |
| 70 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.16587983 |
| 71 | IMP biosynthetic process (GO:0006188) | 3.16047588 |
| 72 | mitotic metaphase plate congression (GO:0007080) | 3.15925722 |
| 73 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.15020699 |
| 74 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.15020699 |
| 75 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.14232709 |
| 76 | protein K6-linked ubiquitination (GO:0085020) | 3.13797187 |
| 77 | ribosome biogenesis (GO:0042254) | 3.12872745 |
| 78 | complement activation, alternative pathway (GO:0006957) | 3.12386538 |
| 79 | maturation of SSU-rRNA (GO:0030490) | 3.11107527 |
| 80 | rRNA metabolic process (GO:0016072) | 3.09616739 |
| 81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.09310710 |
| 82 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08135840 |
| 83 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08135840 |
| 84 | modulation by symbiont of host immune response (GO:0052553) | 3.08135840 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08135840 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 3.08135840 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08135840 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 3.07710946 |
| 89 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.06767213 |
| 90 | response to peptidoglycan (GO:0032494) | 3.05249885 |
| 91 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.04686731 |
| 92 | DNA double-strand break processing (GO:0000729) | 3.03877171 |
| 93 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.03036278 |
| 94 | base-excision repair, AP site formation (GO:0006285) | 3.02226221 |
| 95 | tRNA methylation (GO:0030488) | 3.02047877 |
| 96 | tRNA processing (GO:0008033) | 3.01553138 |
| 97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.01423767 |
| 98 | protein localization to chromosome, centromeric region (GO:0071459) | 3.01419412 |
| 99 | tRNA metabolic process (GO:0006399) | 3.00122267 |
| 100 | folic acid metabolic process (GO:0046655) | 3.00086444 |
| 101 | tRNA modification (GO:0006400) | 3.00024256 |
| 102 | GMP metabolic process (GO:0046037) | 2.99429426 |
| 103 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.99297555 |
| 104 | low-density lipoprotein particle remodeling (GO:0034374) | 2.98277639 |
| 105 | ribosomal large subunit biogenesis (GO:0042273) | 2.98004674 |
| 106 | telomere maintenance via recombination (GO:0000722) | 2.97372086 |
| 107 | respiratory burst (GO:0045730) | 2.96385621 |
| 108 | replication fork processing (GO:0031297) | 2.95462182 |
| 109 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.94690992 |
| 110 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.93261017 |
| 111 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.93180793 |
| 112 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.93180793 |
| 113 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.93180793 |
| 114 | protein targeting to mitochondrion (GO:0006626) | 2.92950699 |
| 115 | mitotic sister chromatid segregation (GO:0000070) | 2.91364049 |
| 116 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.90309655 |
| 117 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.90309655 |
| 118 | establishment of integrated proviral latency (GO:0075713) | 2.90286054 |
| 119 | purine ribonucleotide transport (GO:0015868) | 2.89191274 |
| 120 | cellular component biogenesis (GO:0044085) | 2.88375706 |
| 121 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.87999832 |
| 122 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.87999832 |
| 123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.87665016 |
| 124 | tRNA aminoacylation (GO:0043039) | 2.87572267 |
| 125 | amino acid activation (GO:0043038) | 2.87572267 |
| 126 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.87499526 |
| 127 | ncRNA processing (GO:0034470) | 2.87142694 |
| 128 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.86967571 |
| 129 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.86967571 |
| 130 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.86916176 |
| 131 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.86916176 |
| 132 | bile acid metabolic process (GO:0008206) | 2.86787598 |
| 133 | translation (GO:0006412) | 2.85984911 |
| 134 | ncRNA metabolic process (GO:0034660) | 2.85533546 |
| 135 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.84574500 |
| 136 | mannosylation (GO:0097502) | 2.84462578 |
| 137 | mitotic recombination (GO:0006312) | 2.83878034 |
| 138 | tRNA aminoacylation for protein translation (GO:0006418) | 2.83639715 |
| 139 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.83430711 |
| 140 | regulation of protein activation cascade (GO:2000257) | 2.83398034 |
| 141 | glyoxylate metabolic process (GO:0046487) | 2.83054295 |
| 142 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.82738515 |
| 143 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.82495255 |
| 144 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82309919 |
| 145 | ATP synthesis coupled proton transport (GO:0015986) | 2.82058256 |
| 146 | cysteine metabolic process (GO:0006534) | 2.78859133 |
| 147 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.77466543 |
| 148 | plasma lipoprotein particle clearance (GO:0034381) | 2.77164583 |
| 149 | high-density lipoprotein particle remodeling (GO:0034375) | 2.74803299 |
| 150 | regulation of fibrinolysis (GO:0051917) | 2.74024771 |
| 151 | phospholipid efflux (GO:0033700) | 2.73208501 |
| 152 | urea cycle (GO:0000050) | 2.71236753 |
| 153 | urea metabolic process (GO:0019627) | 2.71236753 |
| 154 | nucleotide transport (GO:0006862) | 2.70977014 |
| 155 | regulation of cholesterol esterification (GO:0010872) | 2.70903716 |
| 156 | regulation of complement activation (GO:0030449) | 2.67620973 |
| 157 | detection of other organism (GO:0098543) | 2.67064571 |
| 158 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.65524857 |
| 159 | alpha-linolenic acid metabolic process (GO:0036109) | 2.65093052 |
| 160 | neutrophil activation involved in immune response (GO:0002283) | 2.64477490 |
| 161 | plasma lipoprotein particle remodeling (GO:0034369) | 2.64388925 |
| 162 | protein-lipid complex remodeling (GO:0034368) | 2.64388925 |
| 163 | macromolecular complex remodeling (GO:0034367) | 2.64388925 |
| 164 | amino-acid betaine metabolic process (GO:0006577) | 2.63657646 |
| 165 | negative regulation of lipase activity (GO:0060192) | 2.61387677 |
| 166 | cofactor catabolic process (GO:0051187) | 2.60562147 |
| 167 | regulation of triglyceride catabolic process (GO:0010896) | 2.59841356 |
| 168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.59070381 |
| 169 | detection of external biotic stimulus (GO:0098581) | 2.57555081 |
| 170 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.57277469 |
| 171 | positive regulation of interferon-alpha production (GO:0032727) | 2.54588283 |
| 172 | blood coagulation, intrinsic pathway (GO:0007597) | 2.54499482 |
| 173 | regulation of RIG-I signaling pathway (GO:0039535) | 2.54231117 |
| 174 | opsonization (GO:0008228) | 2.52964896 |
| 175 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.52776930 |
| 176 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.52776930 |
| 177 | negative regulation of fibrinolysis (GO:0051918) | 2.52147875 |
| 178 | acylglycerol homeostasis (GO:0055090) | 2.51218980 |
| 179 | triglyceride homeostasis (GO:0070328) | 2.51218980 |
| 180 | alpha-amino acid catabolic process (GO:1901606) | 2.50319824 |
| 181 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.50221547 |
| 182 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.50221547 |
| 183 | benzene-containing compound metabolic process (GO:0042537) | 2.48046011 |
| 184 | branched-chain amino acid catabolic process (GO:0009083) | 2.48025681 |
| 185 | acute-phase response (GO:0006953) | 2.45849714 |
| 186 | phagocytosis, recognition (GO:0006910) | 2.45504936 |
| 187 | sulfur amino acid catabolic process (GO:0000098) | 2.44671936 |
| 188 | drug transmembrane transport (GO:0006855) | 2.43909524 |
| 189 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.42932173 |
| 190 | androgen biosynthetic process (GO:0006702) | 2.42438775 |
| 191 | nitrogen cycle metabolic process (GO:0071941) | 2.40731376 |
| 192 | regulation of hexokinase activity (GO:1903299) | 2.40721497 |
| 193 | regulation of glucokinase activity (GO:0033131) | 2.40721497 |
| 194 | cellular glucuronidation (GO:0052695) | 2.38954410 |
| 195 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.37048209 |
| 196 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37027585 |
| 197 | coenzyme catabolic process (GO:0009109) | 2.36033057 |
| 198 | regulation of interferon-alpha production (GO:0032647) | 2.35432988 |
| 199 | branched-chain amino acid metabolic process (GO:0009081) | 2.34721661 |
| 200 | protein activation cascade (GO:0072376) | 2.34106890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.60557831 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.09609121 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.06953694 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.87062482 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.12989547 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09022364 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.97584860 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.90567289 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.85463340 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.73913002 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.42638650 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.36150969 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.33041973 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.21013390 |
| 15 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.12871425 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.07003054 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.01007029 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99936628 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97221202 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.93133218 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.88132603 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.87341338 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82541441 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.81664563 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.79152791 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.73274691 |
| 27 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.72838877 |
| 28 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.70065043 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.68649240 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.67987684 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.64129744 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.63751971 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.54353673 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.43492567 |
| 35 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.39815729 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.36713542 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.30501565 |
| 38 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.28818325 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26994561 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.26488611 |
| 41 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.25250464 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.25155832 |
| 43 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22107731 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.20058004 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19761375 |
| 46 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.16472007 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15421348 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12081742 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11379699 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10880520 |
| 51 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07283944 |
| 52 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.06398887 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05221130 |
| 54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90501505 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.81399224 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.80152470 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79550185 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79022317 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75878767 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74673725 |
| 61 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.73278496 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.69963593 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.69130211 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.68918681 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68388156 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.65058825 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64084670 |
| 68 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.63730412 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55372641 |
| 70 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.54921964 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53047596 |
| 72 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50294318 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48342792 |
| 74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47107988 |
| 75 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44757763 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44079664 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44062865 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43461018 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42492420 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.41102646 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40191817 |
| 82 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40189265 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39831674 |
| 84 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38173941 |
| 85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37634646 |
| 86 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34730124 |
| 87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34267320 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34026825 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32999548 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32355195 |
| 91 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31562798 |
| 92 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.30317234 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29837437 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27880550 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27670578 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26579111 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25812552 |
| 98 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25226236 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25089734 |
| 100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25027720 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24490548 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21282807 |
| 103 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20146941 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18500343 |
| 105 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16979498 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14768537 |
| 107 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.14110004 |
| 108 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13212307 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12227457 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11551658 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11197479 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08699044 |
| 113 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.08619498 |
| 114 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08312538 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08245392 |
| 116 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08220862 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07187196 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06889583 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06450694 |
| 120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06084792 |
| 121 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05985972 |
| 122 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03372889 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03043623 |
| 124 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.01975078 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01876496 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01749952 |
| 127 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01161379 |
| 128 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00983888 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00892045 |
| 130 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.00788161 |
| 131 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00358057 |
| 132 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00321626 |
| 133 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99879588 |
| 134 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97916151 |
| 135 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97734672 |
| 136 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97689766 |
| 137 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97574418 |
| 138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96253930 |
| 139 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96202401 |
| 140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95884839 |
| 141 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95601918 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95459432 |
| 143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95448921 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95448921 |
| 145 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.94840824 |
| 146 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93377432 |
| 147 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92904911 |
| 148 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.92598439 |
| 149 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92325250 |
| 150 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91333515 |
| 151 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91074533 |
| 152 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91010976 |
| 153 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.90769092 |
| 154 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90200168 |
| 155 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.89030439 |
| 156 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.88156214 |
| 157 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.87917517 |
| 158 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87644174 |
| 159 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87052390 |
| 160 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85346018 |
| 161 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85084173 |
| 162 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84997468 |
| 163 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.84689417 |
| 164 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.78638083 |
| 165 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76868730 |
| 166 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.75253537 |
| 167 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75166026 |
| 168 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74651891 |
| 169 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.74001798 |
| 170 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.71032178 |
| 171 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.70875335 |
| 172 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.70389316 |
| 173 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.68746671 |
| 174 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.68592874 |
| 175 | EWS_26573619_Chip-Seq_HEK293_Human | 0.64883914 |
| 176 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.64117574 |
| 177 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.64001965 |
| 178 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.63362491 |
| 179 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.61486341 |
| 180 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.61012888 |
| 181 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.59285267 |
| 182 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.59203422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 4.73394587 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.69367470 |
| 3 | MP0008058_abnormal_DNA_repair | 4.28440959 |
| 4 | MP0003693_abnormal_embryo_hatching | 4.27293924 |
| 5 | MP0005360_urolithiasis | 4.11404940 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.99913654 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.62085514 |
| 8 | MP0003077_abnormal_cell_cycle | 3.47320210 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.38820539 |
| 10 | MP0005365_abnormal_bile_salt | 3.31958277 |
| 11 | MP0003786_premature_aging | 2.99325492 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.90824203 |
| 13 | MP0008932_abnormal_embryonic_tissue | 2.77036098 |
| 14 | MP0003195_calcinosis | 2.71418659 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.71083958 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.68138795 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58182085 |
| 18 | MP0003718_maternal_effect | 2.42410951 |
| 19 | MP0003724_increased_susceptibility_to | 2.08434615 |
| 20 | MP0003252_abnormal_bile_duct | 2.07340195 |
| 21 | MP0002419_abnormal_innate_immunity | 2.06047339 |
| 22 | MP0003436_decreased_susceptibility_to | 2.04798303 |
| 23 | MP0009697_abnormal_copulation | 2.01835228 |
| 24 | MP0009785_altered_susceptibility_to | 1.99332623 |
| 25 | MP0006082_CNS_inflammation | 1.96178057 |
| 26 | MP0003941_abnormal_skin_development | 1.94802736 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.90829274 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 1.89447912 |
| 29 | MP0001764_abnormal_homeostasis | 1.83873057 |
| 30 | MP0009840_abnormal_foam_cell | 1.82976110 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.81308184 |
| 32 | MP0005671_abnormal_response_to | 1.79369720 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.75102366 |
| 34 | MP0005025_abnormal_response_to | 1.74674280 |
| 35 | MP0001661_extended_life_span | 1.74410605 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.74228027 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.72627924 |
| 38 | MP0008260_abnormal_autophagy | 1.72142043 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.71439110 |
| 40 | MP0002102_abnormal_ear_morphology | 1.71197608 |
| 41 | MP0003186_abnormal_redox_activity | 1.70722382 |
| 42 | MP0001790_abnormal_immune_system | 1.68217479 |
| 43 | MP0005387_immune_system_phenotype | 1.68217479 |
| 44 | MP0000350_abnormal_cell_proliferation | 1.67326152 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.67101084 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.64369171 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.54714051 |
| 48 | MP0009764_decreased_sensitivity_to | 1.52158293 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.50137347 |
| 50 | MP0005332_abnormal_amino_acid | 1.48795055 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.44269076 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.44116106 |
| 53 | MP0000358_abnormal_cell_content/ | 1.43425521 |
| 54 | MP0005380_embryogenesis_phenotype | 1.43171894 |
| 55 | MP0001672_abnormal_embryogenesis/_devel | 1.43171894 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.42612128 |
| 57 | MP0001800_abnormal_humoral_immune | 1.42160618 |
| 58 | MP0005408_hypopigmentation | 1.42071350 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.39135002 |
| 60 | MP0003868_abnormal_feces_composition | 1.38675582 |
| 61 | MP0002723_abnormal_immune_serum | 1.38096817 |
| 62 | MP0008469_abnormal_protein_level | 1.38077307 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.37641059 |
| 64 | MP0000685_abnormal_immune_system | 1.37358728 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.34050641 |
| 66 | MP0000313_abnormal_cell_death | 1.33665537 |
| 67 | MP0003315_abnormal_perineum_morphology | 1.32867292 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.32722640 |
| 69 | MP0002160_abnormal_reproductive_system | 1.32512396 |
| 70 | MP0001730_embryonic_growth_arrest | 1.32115545 |
| 71 | MP0005083_abnormal_biliary_tract | 1.31170478 |
| 72 | MP0001529_abnormal_vocalization | 1.30985342 |
| 73 | MP0008057_abnormal_DNA_replication | 1.30664030 |
| 74 | MP0000609_abnormal_liver_physiology | 1.29983896 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.28320690 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 1.27184962 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 1.27071671 |
| 78 | MP0003984_embryonic_growth_retardation | 1.25965701 |
| 79 | MP0001819_abnormal_immune_cell | 1.23890058 |
| 80 | MP0005389_reproductive_system_phenotype | 1.23659697 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.23349565 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.23001268 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.22621177 |
| 84 | MP0009763_increased_sensitivity_to | 1.22103122 |
| 85 | MP0010307_abnormal_tumor_latency | 1.21949747 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.21790946 |
| 87 | MP0002019_abnormal_tumor_incidence | 1.20089829 |
| 88 | MP0008877_abnormal_DNA_methylation | 1.19957838 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 1.19851064 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.19192989 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 1.19051250 |
| 92 | MP0002132_abnormal_respiratory_system | 1.18207704 |
| 93 | MP0005501_abnormal_skin_physiology | 1.18037289 |
| 94 | MP0001697_abnormal_embryo_size | 1.16572752 |
| 95 | MP0009643_abnormal_urine_homeostasis | 1.16185171 |
| 96 | MP0001293_anophthalmia | 1.14023461 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.12696408 |
| 98 | MP0002095_abnormal_skin_pigmentation | 1.12002640 |
| 99 | MP0001533_abnormal_skeleton_physiology | 1.10580698 |
| 100 | MP0003690_abnormal_glial_cell | 1.09829430 |
| 101 | MP0000490_abnormal_crypts_of | 1.09581251 |
| 102 | MP0002080_prenatal_lethality | 1.09553835 |
| 103 | MP0001324_abnormal_eye_pigmentation | 1.08071030 |
| 104 | MP0002084_abnormal_developmental_patter | 1.06546141 |
| 105 | MP0005670_abnormal_white_adipose | 1.06535789 |
| 106 | MP0000647_abnormal_sebaceous_gland | 1.03934121 |
| 107 | MP0003183_abnormal_peptide_metabolism | 1.03271735 |
| 108 | MP0001919_abnormal_reproductive_system | 1.02526947 |
| 109 | MP0000537_abnormal_urethra_morphology | 1.02039723 |
| 110 | MP0003937_abnormal_limbs/digits/tail_de | 1.01988723 |
| 111 | MP0010155_abnormal_intestine_physiology | 1.01679433 |
| 112 | MP0005379_endocrine/exocrine_gland_phen | 1.01511026 |
| 113 | MP0005451_abnormal_body_composition | 0.96490048 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96072805 |
| 115 | MP0000716_abnormal_immune_system | 0.95292681 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.93963687 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.93058664 |
| 118 | MP0001853_heart_inflammation | 0.92838683 |
| 119 | MP0002085_abnormal_embryonic_tissue | 0.92552343 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.92114275 |
| 121 | MP0004381_abnormal_hair_follicle | 0.90675368 |
| 122 | MP0005647_abnormal_sex_gland | 0.89610921 |
| 123 | MP0000598_abnormal_liver_morphology | 0.89472496 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.89181201 |
| 125 | MP0002090_abnormal_vision | 0.87496027 |
| 126 | MP0005171_absent_coat_pigmentation | 0.86624248 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.86300103 |
| 128 | MP0003763_abnormal_thymus_physiology | 0.85294401 |
| 129 | MP0004133_heterotaxia | 0.84984485 |
| 130 | MP0004147_increased_porphyrin_level | 0.83697816 |
| 131 | MP0004197_abnormal_fetal_growth/weight/ | 0.83443511 |
| 132 | MP0002111_abnormal_tail_morphology | 0.83161733 |
| 133 | MP0002933_joint_inflammation | 0.83078234 |
| 134 | MP0001145_abnormal_male_reproductive | 0.82822028 |
| 135 | MP0001542_abnormal_bone_strength | 0.82465123 |
| 136 | MP0001929_abnormal_gametogenesis | 0.82222215 |
| 137 | MP0002396_abnormal_hematopoietic_system | 0.81781476 |
| 138 | MP0002429_abnormal_blood_cell | 0.81071651 |
| 139 | MP0005253_abnormal_eye_physiology | 0.80267861 |
| 140 | MP0002398_abnormal_bone_marrow | 0.80159430 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.79749033 |
| 142 | MP0001881_abnormal_mammary_gland | 0.79701878 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.78902884 |
| 144 | MP0002938_white_spotting | 0.78186002 |
| 145 | MP0000920_abnormal_myelination | 0.77049824 |
| 146 | MP0002210_abnormal_sex_determination | 0.76698659 |
| 147 | MP0005220_abnormal_exocrine_pancreas | 0.76500741 |
| 148 | MP0000371_diluted_coat_color | 0.76264964 |
| 149 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75786948 |
| 150 | MP0005334_abnormal_fat_pad | 0.74991516 |
| 151 | MP0002998_abnormal_bone_remodeling | 0.74900210 |
| 152 | MP0006054_spinal_hemorrhage | 0.74555867 |
| 153 | MP0001186_pigmentation_phenotype | 0.74199201 |
| 154 | MP0005499_abnormal_olfactory_system | 0.74057272 |
| 155 | MP0005394_taste/olfaction_phenotype | 0.74057272 |
| 156 | MP0002722_abnormal_immune_system | 0.73982547 |
| 157 | MP0002638_abnormal_pupillary_reflex | 0.73955700 |
| 158 | MP0005164_abnormal_response_to | 0.73752609 |
| 159 | MP0000653_abnormal_sex_gland | 0.73207182 |
| 160 | MP0001119_abnormal_female_reproductive | 0.71620266 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.70926872 |
| 162 | MP0002928_abnormal_bile_duct | 0.70634644 |
| 163 | MP0002006_tumorigenesis | 0.70154694 |
| 164 | MP0001545_abnormal_hematopoietic_system | 0.69923626 |
| 165 | MP0005397_hematopoietic_system_phenotyp | 0.69923626 |
| 166 | MP0002075_abnormal_coat/hair_pigmentati | 0.67035029 |
| 167 | MP0000703_abnormal_thymus_morphology | 0.66699387 |
| 168 | MP0000427_abnormal_hair_cycle | 0.65767024 |
| 169 | MP0002254_reproductive_system_inflammat | 0.64811472 |
| 170 | MP0008873_increased_physiological_sensi | 0.64773669 |
| 171 | MP0002086_abnormal_extraembryonic_tissu | 0.64045514 |
| 172 | MP0005395_other_phenotype | 0.62737962 |
| 173 | MP0002796_impaired_skin_barrier | 0.62120685 |
| 174 | MP0004808_abnormal_hematopoietic_stem | 0.61768246 |
| 175 | MP0000465_gastrointestinal_hemorrhage | 0.61050009 |
| 176 | MP0005384_cellular_phenotype | 0.60428185 |
| 177 | MP0008995_early_reproductive_senescence | 0.60418817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 4.60696064 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.32336607 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.16512797 |
| 4 | Joint hemorrhage (HP:0005261) | 3.97901244 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 3.71046922 |
| 6 | Generalized aminoaciduria (HP:0002909) | 3.67100889 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66923508 |
| 8 | Increased CSF lactate (HP:0002490) | 3.59040388 |
| 9 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55551176 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44878394 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.43944289 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 3.41638017 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.41365789 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.37997789 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.34147767 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.32012136 |
| 17 | Microvesicular hepatic steatosis (HP:0001414) | 3.26946469 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.24523104 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.23181351 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 3.22998118 |
| 21 | Xanthomatosis (HP:0000991) | 3.20234987 |
| 22 | Acute encephalopathy (HP:0006846) | 3.17421986 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12954010 |
| 24 | Increased serum lactate (HP:0002151) | 3.09261863 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.07327324 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.03792452 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96862904 |
| 28 | Hepatic necrosis (HP:0002605) | 2.95175617 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.93214807 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 2.88698164 |
| 31 | Methylmalonic acidemia (HP:0002912) | 2.87087804 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82946126 |
| 33 | Deep venous thrombosis (HP:0002625) | 2.81141390 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.80909460 |
| 35 | Birth length less than 3rd percentile (HP:0003561) | 2.80391407 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 2.79622703 |
| 37 | Hypoplasia of the pons (HP:0012110) | 2.78522754 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.74922628 |
| 39 | Complement deficiency (HP:0004431) | 2.74608612 |
| 40 | Methylmalonic aciduria (HP:0012120) | 2.74061989 |
| 41 | Meckel diverticulum (HP:0002245) | 2.73299700 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.68335948 |
| 43 | Hypobetalipoproteinemia (HP:0003563) | 2.66885267 |
| 44 | Colon cancer (HP:0003003) | 2.65528494 |
| 45 | Gingival bleeding (HP:0000225) | 2.65241354 |
| 46 | Fat malabsorption (HP:0002630) | 2.63649712 |
| 47 | Abnormality of the ileum (HP:0001549) | 2.63017050 |
| 48 | Lactic acidosis (HP:0003128) | 2.59755301 |
| 49 | Abnormality of alanine metabolism (HP:0010916) | 2.59259565 |
| 50 | Hyperalaninemia (HP:0003348) | 2.59259565 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59259565 |
| 52 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.55847338 |
| 53 | Renal cortical cysts (HP:0000803) | 2.53495270 |
| 54 | Abnormality of the pons (HP:0007361) | 2.53142366 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.51175198 |
| 56 | Progressive macrocephaly (HP:0004481) | 2.47964856 |
| 57 | Pancreatic cysts (HP:0001737) | 2.43095816 |
| 58 | Prostate neoplasm (HP:0100787) | 2.43046149 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.42494148 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.42025617 |
| 61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.39294501 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.39263079 |
| 63 | Renal Fanconi syndrome (HP:0001994) | 2.39229294 |
| 64 | Abnormality of the preputium (HP:0100587) | 2.38480458 |
| 65 | Steatorrhea (HP:0002570) | 2.38299482 |
| 66 | Poor head control (HP:0002421) | 2.38253776 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.35871595 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.35871595 |
| 69 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.35076986 |
| 70 | Epistaxis (HP:0000421) | 2.33012012 |
| 71 | * Abnormal protein glycosylation (HP:0012346) | 2.33008193 |
| 72 | * Abnormal glycosylation (HP:0012345) | 2.33008193 |
| 73 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33008193 |
| 74 | * Abnormal protein N-linked glycosylation (HP:0012347) | 2.33008193 |
| 75 | Hepatosplenomegaly (HP:0001433) | 2.31779977 |
| 76 | Patchy hypopigmentation of hair (HP:0011365) | 2.30790770 |
| 77 | Pancytopenia (HP:0001876) | 2.30503277 |
| 78 | Cerebral edema (HP:0002181) | 2.29814713 |
| 79 | 3-Methylglutaconic aciduria (HP:0003535) | 2.26195754 |
| 80 | Recurrent skin infections (HP:0001581) | 2.25558309 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.25242466 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23094326 |
| 83 | Hypothermia (HP:0002045) | 2.21441649 |
| 84 | Opisthotonus (HP:0002179) | 2.21009637 |
| 85 | Progressive muscle weakness (HP:0003323) | 2.18849176 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.18641447 |
| 87 | Type II lissencephaly (HP:0007260) | 2.17378795 |
| 88 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.17065438 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 2.15844357 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15844357 |
| 91 | Horseshoe kidney (HP:0000085) | 2.15513632 |
| 92 | Respiratory difficulties (HP:0002880) | 2.15105426 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13935355 |
| 94 | Epidermoid cyst (HP:0200040) | 2.13455609 |
| 95 | Abnormality of chromosome stability (HP:0003220) | 2.13440415 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13206284 |
| 97 | Hypoplasia of the uterus (HP:0000013) | 2.12614496 |
| 98 | Myocardial infarction (HP:0001658) | 2.12470780 |
| 99 | Hypoglycemic coma (HP:0001325) | 2.11764300 |
| 100 | White forelock (HP:0002211) | 2.11711737 |
| 101 | Abnormality of complement system (HP:0005339) | 2.11069451 |
| 102 | Cleft eyelid (HP:0000625) | 2.10805588 |
| 103 | Abnormality of macrophages (HP:0004311) | 2.10244879 |
| 104 | Axonal loss (HP:0003447) | 2.09169915 |
| 105 | Purpura (HP:0000979) | 2.08261445 |
| 106 | Increased serum pyruvate (HP:0003542) | 2.06960127 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 2.06498896 |
| 108 | Thrombocytosis (HP:0001894) | 2.05289516 |
| 109 | Prolonged neonatal jaundice (HP:0006579) | 2.04524237 |
| 110 | Pendular nystagmus (HP:0012043) | 2.04300187 |
| 111 | Reticulocytopenia (HP:0001896) | 2.03983073 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 2.03875689 |
| 113 | Microretrognathia (HP:0000308) | 2.03873804 |
| 114 | Squamous cell carcinoma (HP:0002860) | 2.02707520 |
| 115 | Menorrhagia (HP:0000132) | 2.01935362 |
| 116 | Death in infancy (HP:0001522) | 2.00545549 |
| 117 | Increased muscle lipid content (HP:0009058) | 1.99696747 |
| 118 | Sloping forehead (HP:0000340) | 1.99546041 |
| 119 | Vasculitis (HP:0002633) | 1.99410447 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 1.98904826 |
| 121 | Sparse eyelashes (HP:0000653) | 1.98827058 |
| 122 | Dicarboxylic aciduria (HP:0003215) | 1.98449218 |
| 123 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98449218 |
| 124 | Recurrent pneumonia (HP:0006532) | 1.98398709 |
| 125 | Prolonged bleeding time (HP:0003010) | 1.97429180 |
| 126 | Myositis (HP:0100614) | 1.97313166 |
| 127 | Symptomatic seizures (HP:0011145) | 1.97255137 |
| 128 | Periodontitis (HP:0000704) | 1.96754127 |
| 129 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.96281718 |
| 130 | Abnormality of glycolysis (HP:0004366) | 1.95712138 |
| 131 | IgM deficiency (HP:0002850) | 1.95679134 |
| 132 | Hyperammonemia (HP:0001987) | 1.95219303 |
| 133 | Vascular calcification (HP:0004934) | 1.94728796 |
| 134 | Pancreatic fibrosis (HP:0100732) | 1.93774869 |
| 135 | Lethargy (HP:0001254) | 1.93555320 |
| 136 | Orchitis (HP:0100796) | 1.93429650 |
| 137 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93179755 |
| 138 | Absent thumb (HP:0009777) | 1.91889216 |
| 139 | Macrocytic anemia (HP:0001972) | 1.91761346 |
| 140 | Enlarged kidneys (HP:0000105) | 1.91634582 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.90553832 |
| 142 | Abnormality of the renal collecting system (HP:0004742) | 1.90051323 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89451622 |
| 144 | CNS demyelination (HP:0007305) | 1.88709816 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.88602065 |
| 146 | Selective tooth agenesis (HP:0001592) | 1.88067126 |
| 147 | Retrobulbar optic neuritis (HP:0100654) | 1.87604016 |
| 148 | Optic neuritis (HP:0100653) | 1.87604016 |
| 149 | Medial flaring of the eyebrow (HP:0010747) | 1.87549933 |
| 150 | Glomerulonephritis (HP:0000099) | 1.87358043 |
| 151 | Postnatal microcephaly (HP:0005484) | 1.87331958 |
| 152 | Hypolipoproteinemia (HP:0010981) | 1.87221391 |
| 153 | Testicular atrophy (HP:0000029) | 1.87185431 |
| 154 | Small intestinal stenosis (HP:0012848) | 1.86517765 |
| 155 | Duodenal stenosis (HP:0100867) | 1.86517765 |
| 156 | Progressive microcephaly (HP:0000253) | 1.86021937 |
| 157 | Gingivitis (HP:0000230) | 1.84470461 |
| 158 | Respiratory failure (HP:0002878) | 1.84441369 |
| 159 | Proximal tubulopathy (HP:0000114) | 1.84341886 |
| 160 | CNS hypomyelination (HP:0003429) | 1.83136304 |
| 161 | IgG deficiency (HP:0004315) | 1.83102783 |
| 162 | Neutropenia (HP:0001875) | 1.82707334 |
| 163 | Myelodysplasia (HP:0002863) | 1.82427274 |
| 164 | Chromsome breakage (HP:0040012) | 1.81554606 |
| 165 | Nausea (HP:0002018) | 1.81423342 |
| 166 | Hyperglycinuria (HP:0003108) | 1.81293422 |
| 167 | Alveolar cell carcinoma (HP:0006519) | 1.81204790 |
| 168 | Abnormal biliary tract physiology (HP:0012439) | 1.80516909 |
| 169 | Bile duct proliferation (HP:0001408) | 1.80516909 |
| 170 | Degeneration of anterior horn cells (HP:0002398) | 1.80494866 |
| 171 | Abnormality of the anterior horn cell (HP:0006802) | 1.80494866 |
| 172 | Entropion (HP:0000621) | 1.80220934 |
| 173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79840228 |
| 174 | Congenital primary aphakia (HP:0007707) | 1.78538931 |
| 175 | Hypercholesterolemia (HP:0003124) | 1.78497981 |
| 176 | Nonimmune hydrops fetalis (HP:0001790) | 1.77824867 |
| 177 | Recurrent fungal infections (HP:0002841) | 1.77765665 |
| 178 | Elevated hepatic transaminases (HP:0002910) | 1.77514363 |
| 179 | Hypoplasia of the thymus (HP:0000778) | 1.77181144 |
| 180 | Granulocytopenia (HP:0001913) | 1.77110126 |
| 181 | Autoimmune thrombocytopenia (HP:0001973) | 1.76952633 |
| 182 | Hyperglycinemia (HP:0002154) | 1.76735070 |
| 183 | Secondary amenorrhea (HP:0000869) | 1.76251505 |
| 184 | Exertional dyspnea (HP:0002875) | 1.75718353 |
| 185 | Brittle hair (HP:0002299) | 1.75289421 |
| 186 | Abnormality of midbrain morphology (HP:0002418) | 1.74763042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.49125713 |
| 2 | SRPK1 | 4.33111434 |
| 3 | BUB1 | 3.86463614 |
| 4 | IRAK3 | 3.75144565 |
| 5 | NEK1 | 3.11254009 |
| 6 | IRAK4 | 3.01564792 |
| 7 | CDC7 | 2.99248002 |
| 8 | MAP3K14 | 2.58532964 |
| 9 | EPHB1 | 2.53457261 |
| 10 | ERN1 | 2.44257214 |
| 11 | FGFR4 | 2.22032678 |
| 12 | TTK | 2.18705293 |
| 13 | TXK | 2.11074251 |
| 14 | ZAK | 2.04509159 |
| 15 | FRK | 1.97306665 |
| 16 | BMPR1B | 1.96731791 |
| 17 | STK16 | 1.93502909 |
| 18 | IRAK1 | 1.92089032 |
| 19 | EPHA3 | 1.84332374 |
| 20 | TAF1 | 1.84298774 |
| 21 | BMPR2 | 1.82940394 |
| 22 | MAP4K2 | 1.82708797 |
| 23 | TYK2 | 1.82468406 |
| 24 | CDK8 | 1.82078506 |
| 25 | KIT | 1.81745141 |
| 26 | PBK | 1.74823511 |
| 27 | PLK3 | 1.72570498 |
| 28 | PLK4 | 1.72313275 |
| 29 | TRPM7 | 1.68368300 |
| 30 | MKNK1 | 1.65894110 |
| 31 | TBK1 | 1.64601395 |
| 32 | IKBKE | 1.63653936 |
| 33 | MAP4K1 | 1.57244460 |
| 34 | BCKDK | 1.55998383 |
| 35 | BLK | 1.54269495 |
| 36 | TAOK3 | 1.49784973 |
| 37 | JAK3 | 1.47743367 |
| 38 | MST4 | 1.47384489 |
| 39 | TGFBR2 | 1.46862134 |
| 40 | NUAK1 | 1.46665803 |
| 41 | CHEK2 | 1.45692715 |
| 42 | TEC | 1.43108747 |
| 43 | JAK1 | 1.39260274 |
| 44 | IKBKB | 1.38903823 |
| 45 | EIF2AK3 | 1.37205183 |
| 46 | NME1 | 1.36163474 |
| 47 | INSRR | 1.35809063 |
| 48 | PLK1 | 1.31580736 |
| 49 | BTK | 1.29898946 |
| 50 | TRIM28 | 1.28923360 |
| 51 | MKNK2 | 1.25494803 |
| 52 | STK24 | 1.25342363 |
| 53 | RPS6KA4 | 1.24102829 |
| 54 | CSNK1G1 | 1.22980779 |
| 55 | NLK | 1.22559694 |
| 56 | TSSK6 | 1.22138130 |
| 57 | EIF2AK2 | 1.19984370 |
| 58 | GRK1 | 1.19760567 |
| 59 | CSF1R | 1.19650726 |
| 60 | CSNK1G3 | 1.16153794 |
| 61 | AURKB | 1.14354384 |
| 62 | CDK7 | 1.10323014 |
| 63 | NEK2 | 1.08903969 |
| 64 | CLK1 | 1.08130564 |
| 65 | WEE1 | 1.06539345 |
| 66 | CAMK1D | 1.05630681 |
| 67 | BRSK2 | 1.03514161 |
| 68 | CDK9 | 1.03239306 |
| 69 | NEK6 | 1.01681113 |
| 70 | ERBB3 | 0.99422869 |
| 71 | MAP3K4 | 0.98374496 |
| 72 | WNK3 | 0.97325208 |
| 73 | MAP2K7 | 0.97193231 |
| 74 | CSNK1A1L | 0.96997267 |
| 75 | NEK9 | 0.94292043 |
| 76 | LYN | 0.92021472 |
| 77 | AURKA | 0.91715787 |
| 78 | TGFBR1 | 0.89297176 |
| 79 | ZAP70 | 0.89168564 |
| 80 | STK3 | 0.87705556 |
| 81 | YES1 | 0.87597306 |
| 82 | PRPF4B | 0.86550861 |
| 83 | EIF2AK1 | 0.83458037 |
| 84 | IRAK2 | 0.82929502 |
| 85 | CHEK1 | 0.82175745 |
| 86 | MAPK11 | 0.81957621 |
| 87 | PKN1 | 0.78357571 |
| 88 | LCK | 0.78109314 |
| 89 | CDK4 | 0.77993399 |
| 90 | PASK | 0.77873378 |
| 91 | WNK4 | 0.77526710 |
| 92 | SMG1 | 0.77153278 |
| 93 | MAPK15 | 0.76416950 |
| 94 | ADRBK2 | 0.75384065 |
| 95 | CHUK | 0.75294737 |
| 96 | FGFR3 | 0.75233876 |
| 97 | TESK2 | 0.73603496 |
| 98 | OXSR1 | 0.73167633 |
| 99 | BRSK1 | 0.72892686 |
| 100 | ATM | 0.70879582 |
| 101 | CSK | 0.70791046 |
| 102 | MATK | 0.70648970 |
| 103 | ITK | 0.69135932 |
| 104 | STK38L | 0.68134101 |
| 105 | MAPKAPK5 | 0.67805572 |
| 106 | CSNK1G2 | 0.67763478 |
| 107 | PIK3CG | 0.66412300 |
| 108 | SYK | 0.65256287 |
| 109 | GRK7 | 0.64598616 |
| 110 | JAK2 | 0.64447835 |
| 111 | PIM1 | 0.63786222 |
| 112 | PIM2 | 0.61951326 |
| 113 | RPS6KB2 | 0.61796430 |
| 114 | NME2 | 0.61739186 |
| 115 | CSNK2A1 | 0.61708382 |
| 116 | PDK2 | 0.61413712 |
| 117 | DYRK2 | 0.61255622 |
| 118 | ERBB4 | 0.61028693 |
| 119 | PAK4 | 0.60309371 |
| 120 | STK4 | 0.57057210 |
| 121 | CSNK2A2 | 0.56450751 |
| 122 | ABL2 | 0.55217288 |
| 123 | HCK | 0.54908258 |
| 124 | MST1R | 0.54705713 |
| 125 | PRKCD | 0.54127099 |
| 126 | KDR | 0.53721474 |
| 127 | FLT3 | 0.53065421 |
| 128 | PRKCQ | 0.52687302 |
| 129 | PRKG2 | 0.52659397 |
| 130 | CDK19 | 0.52147417 |
| 131 | GRK6 | 0.51399223 |
| 132 | ABL1 | 0.51024365 |
| 133 | VRK1 | 0.50739967 |
| 134 | DAPK1 | 0.47278515 |
| 135 | HIPK2 | 0.46706822 |
| 136 | MAP3K8 | 0.43915951 |
| 137 | DYRK3 | 0.43485369 |
| 138 | LIMK1 | 0.42574126 |
| 139 | STK39 | 0.42498701 |
| 140 | MUSK | 0.41513653 |
| 141 | RPS6KA5 | 0.40977366 |
| 142 | MAP2K3 | 0.40413772 |
| 143 | SIK3 | 0.38144757 |
| 144 | MAP2K2 | 0.37849346 |
| 145 | IGF1R | 0.37597968 |
| 146 | ATR | 0.37369802 |
| 147 | PRKCI | 0.36716762 |
| 148 | CDK6 | 0.34990679 |
| 149 | TLK1 | 0.34898434 |
| 150 | EPHA2 | 0.34869151 |
| 151 | STK10 | 0.34455302 |
| 152 | CDK1 | 0.34153001 |
| 153 | MAPK7 | 0.33713554 |
| 154 | MELK | 0.33617222 |
| 155 | ADRBK1 | 0.33013399 |
| 156 | CDK2 | 0.32111877 |
| 157 | CSNK1A1 | 0.25475853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.15189245 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.14285744 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.06831865 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.96194992 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.85305694 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.81955940 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.79927520 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.62995216 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.58961603 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.30820719 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.30783412 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29739464 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26116496 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.25117523 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.12726413 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10533103 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.10491235 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.09159454 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09146525 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.08170184 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 2.07691219 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.02348434 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99290969 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96999798 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94353283 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.91616041 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.91477056 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86713279 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83082469 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.81274773 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81272586 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.78529812 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.76717291 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73237315 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71138130 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.66155439 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65312727 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60358872 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57945368 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57481132 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.54197941 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53372177 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.51995811 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51186649 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.50728679 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.48477429 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48382195 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46044860 |
| 49 | Cell cycle_Homo sapiens_hsa04110 | 1.45219351 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45005643 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41830209 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38684136 |
| 53 | Purine metabolism_Homo sapiens_hsa00230 | 1.33114672 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28265340 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27439458 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25228842 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23428140 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20411104 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15856477 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15830620 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09508060 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09327970 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07274476 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05874504 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 1.05255439 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04656155 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04383924 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02419864 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00260716 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00107998 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99451513 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94493476 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92832663 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92564745 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92558167 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.91644189 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90880419 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90792839 |
| 79 | Malaria_Homo sapiens_hsa05144 | 0.90356868 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.89434232 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89200360 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87746645 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83250574 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.82892926 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82641804 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80346832 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79768408 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.78410510 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77812067 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77565425 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76235539 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74103898 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73448458 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72882845 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72135305 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.71666515 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69353558 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65761364 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65388436 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65151438 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64721939 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62467346 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62019574 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60347537 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59999749 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59653307 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.57404087 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57139529 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56161209 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55586805 |
| 111 | Proteasome_Homo sapiens_hsa03050 | 0.55582990 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55527728 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54154225 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53621053 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52222767 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51388039 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50133061 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49276524 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.48822163 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48806908 |
| 121 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48805952 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46601134 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45212556 |
| 124 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43819551 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.43770029 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.43488316 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41953693 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41173305 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38507778 |
| 130 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38313138 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38129988 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37404537 |
| 133 | DNA replication_Homo sapiens_hsa03030 | 0.36595530 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.36295403 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.35045292 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.33974220 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27321617 |
| 138 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20563203 |
| 139 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19953498 |
| 140 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19424324 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.19215443 |
| 142 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18293322 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16953687 |

